AIM ImmunoTech Inc

AIM ImmunoTech Inc

AIM

Get informed when a big investor buys or sells

+ Follow
Market Cap$874.71K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
AIM ImmunoTech IncAIM ImmunoTech Inc-0.1--625%-0.2
$-0.29

Current Fair Value

217.1% downside

Overvalued by 217.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$874,710.00
Enterprise Value$-4,581,290.00
Dividend Yield$- (-)
Earnings per Share$-8.62
Beta1.2
Outstanding Shares4,351,449

Return

Return on Equity-624.75%ROE
Return on Assets-154.64%
Return on Invested Capital-339.84%

Valuation & Multiples

P/E Ratio-0.14P/E Ratio
PEG0.77PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-48.74
Enterprise Value to EBIT0.55
Enterprise Value to Net Income0
Total Debt to Enterprise-0.08
Debt to Equity0.17Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 21, 2026
EPS Estimate
$-0.37
Average shareholder expectation
Revenue Estimate
$20,781
Average shareholder expectation

Next Earnings Call

Expected Date
August 13, 2026
EPS Estimate
$-0.17
Average shareholder expectation
Revenue Estimate
$100,000
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %4.04%▲ 4.04%
Total Invested$102,813
Investors Holding18▲ 18.00%

ESG Score

No data

About AIM ImmunoTech Inc

CEO: Thomas Equels